A growing body of evidence points to NT-proBNP as a biomarker for screening, diagnosis, management and follow-up of children with cardiac disease, bronchopulmonary dysplasia, retinopathy and increased risk of intraventricular hemorrhage (IVH) [37–40]. This evidence concerns the gene NPPB and heart disorder.